Third, we evaluated the unique influence of the combined SD/VRFs effect beyond that of the commonly used AD biomarkers, including levels of CSF-Aβ, T-tau, P-tau, and hippocampal volume. The gene discussed is MAPT; the disease is Alzheimer disease.